196 related articles for article (PubMed ID: 21906659)
1. Macroautophagy and the proteasome are differently involved in the degradation of alpha-synuclein wild type and mutated A30P in an in vitro inducible model (PC12/TetOn).
Batelli S; Peverelli E; Rodilossi S; Forloni G; Albani D
Neuroscience; 2011 Nov; 195(4):128-37. PubMed ID: 21906659
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70.
Albani D; Peverelli E; Rametta R; Batelli S; Veschini L; Negro A; Forloni G
FASEB J; 2004 Nov; 18(14):1713-5. PubMed ID: 15345691
[TBL] [Abstract][Full Text] [Related]
3. E46K Mutant α-Synuclein Is Degraded by Both Proteasome and Macroautophagy Pathway.
Yan JQ; Yuan YH; Chu SF; Li GH; Chen NH
Molecules; 2018 Nov; 23(11):. PubMed ID: 30388770
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between the proteasome system and autophagy in the clearance of α-synuclein.
Yang F; Yang YP; Mao CJ; Liu L; Zheng HF; Hu LF; Liu CF
Acta Pharmacol Sin; 2013 May; 34(5):674-80. PubMed ID: 23603979
[TBL] [Abstract][Full Text] [Related]
5. alpha-Synuclein expression levels do not significantly affect proteasome function and expression in mice and stably transfected PC12 cell lines.
Martìn-Clemente B; Alvarez-Castelao B; Mayo I; Sierra AB; Dìaz V; Milán M; Fariñas I; Gómez-Isla T; Ferrer I; Castaño JG
J Biol Chem; 2004 Dec; 279(51):52984-90. PubMed ID: 15466467
[TBL] [Abstract][Full Text] [Related]
6. Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations.
Lewis KA; Yaeger A; DeMartino GN; Thomas PJ
J Bioenerg Biomembr; 2010 Feb; 42(1):85-95. PubMed ID: 20148295
[TBL] [Abstract][Full Text] [Related]
7. Effect of trehalose on PC12 cells overexpressing wild-type or A53T mutant α-synuclein.
Lan DM; Liu FT; Zhao J; Chen Y; Wu JJ; Ding ZT; Yue ZY; Ren HM; Jiang YP; Wang J
Neurochem Res; 2012 Sep; 37(9):2025-32. PubMed ID: 22707286
[TBL] [Abstract][Full Text] [Related]
8. The Parkinson disease-associated A30P mutation stabilizes alpha-synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells.
Song W; Patel A; Qureshi HY; Han D; Schipper HM; Paudel HK
J Neurochem; 2009 Jul; 110(2):719-33. PubMed ID: 19457084
[TBL] [Abstract][Full Text] [Related]
9. Tetramethylpyrazine Analogue T-006 Promotes the Clearance of Alpha-synuclein by Enhancing Proteasome Activity in Parkinson's Disease Models.
Zhou H; Shao M; Guo B; Li C; Lu Y; Yang X; ShengnanLi ; Li H; Zhu Q; Zhong H; Wang Y; Zhang Z; Lu J; Lee SM
Neurotherapeutics; 2019 Oct; 16(4):1225-1236. PubMed ID: 31313223
[TBL] [Abstract][Full Text] [Related]
10. Role of autophagy and proteasome degradation pathways in apoptosis of PC12 cells overexpressing human alpha-synuclein.
Yang F; Yang YP; Mao CJ; Cao BY; Cai ZL; Shi JJ; Huang JZ; Zhang P; Liu CF
Neurosci Lett; 2009 May; 454(3):203-8. PubMed ID: 19429084
[TBL] [Abstract][Full Text] [Related]
11. The role of alpha-synuclein oligomerization and aggregation in cellular and animal models of Parkinson's disease.
Wan OW; Chung KK
PLoS One; 2012; 7(6):e38545. PubMed ID: 22701661
[TBL] [Abstract][Full Text] [Related]
12. alpha-Synuclein budding yeast model: toxicity enhanced by impaired proteasome and oxidative stress.
Sharma N; Brandis KA; Herrera SK; Johnson BE; Vaidya T; Shrestha R; Debburman SK
J Mol Neurosci; 2006; 28(2):161-78. PubMed ID: 16679556
[TBL] [Abstract][Full Text] [Related]
13. Lewy body-like α-synuclein aggregates resist degradation and impair macroautophagy.
Tanik SA; Schultheiss CE; Volpicelli-Daley LA; Brunden KR; Lee VM
J Biol Chem; 2013 May; 288(21):15194-210. PubMed ID: 23532841
[TBL] [Abstract][Full Text] [Related]
14. Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation.
Cai CZ; Zhou HF; Yuan NN; Wu MY; Lee SM; Ren JY; Su HX; Lu JJ; Chen XP; Li M; Tan JQ; Lu JH
Phytomedicine; 2019 Aug; 61():152842. PubMed ID: 31048127
[TBL] [Abstract][Full Text] [Related]
15. The A30P α-synuclein mutation decreases subventricular zone proliferation.
Zhang XM; Anwar S; Kim Y; Brown J; Comte I; Cai H; Cai NN; Wade-Martins R; Szele FG
Hum Mol Genet; 2019 Jul; 28(14):2283-2294. PubMed ID: 31267130
[TBL] [Abstract][Full Text] [Related]
16. Dopamine-mediated oxidation of methionine 127 in α-synuclein causes cytotoxicity and oligomerization of α-synuclein.
Nakaso K; Tajima N; Ito S; Teraoka M; Yamashita A; Horikoshi Y; Kikuchi D; Mochida S; Nakashima K; Matsura T
PLoS One; 2013; 8(2):e55068. PubMed ID: 23457458
[TBL] [Abstract][Full Text] [Related]
17. Suppression of MAPK attenuates neuronal cell death induced by activated glia-conditioned medium in alpha-synuclein overexpressing SH-SY5Y cells.
Yshii LM; Denadai-Souza A; Vasconcelos AR; Avellar MC; Scavone C
J Neuroinflammation; 2015 Oct; 12():193. PubMed ID: 26502720
[TBL] [Abstract][Full Text] [Related]
18. alpha-Synuclein fission yeast model: concentration-dependent aggregation without plasma membrane localization or toxicity.
Brandis KA; Holmes IF; England SJ; Sharma N; Kukreja L; DebBurman SK
J Mol Neurosci; 2006; 28(2):179-91. PubMed ID: 16679557
[TBL] [Abstract][Full Text] [Related]
19. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
Sahay S; Ghosh D; Singh PK; Maji SK
Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity.
Qiao L; Hamamichi S; Caldwell KA; Caldwell GA; Yacoubian TA; Wilson S; Xie ZL; Speake LD; Parks R; Crabtree D; Liang Q; Crimmins S; Schneider L; Uchiyama Y; Iwatsubo T; Zhou Y; Peng L; Lu Y; Standaert DG; Walls KC; Shacka JJ; Roth KA; Zhang J
Mol Brain; 2008 Nov; 1():17. PubMed ID: 19021916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
